- Home
- Products
CELSENTRI (Maraviroc)
CELSENTRI (Maraviroc)
- Medicine Name: CELSENTRI
- Generic Name: Maraviroc
- Dosage Form & Strength: Tablets – 150 mg and 300 mg
- Manufactured By: Pfizer
- FDA Approval Date:Yes
CELSENTRI (Maraviroc) is a CCR5 co-receptor antagonist indicated for use in combination with other antiretroviral agents for the treatment of adults infected with only CCR5-tropic HIV-1, who show evidence of viral replication and resistance to multiple antiretroviral medications.
Recommended Dosage (based on drug interactions):
- With strong CYP3A inhibitors (e.g., most protease inhibitors, delavirdine): 150 mg twice daily
- With non-CYP3A inhibitors/inducers (e.g., NRTIs, nevirapine, tipranavir/ritonavir): 300 mg twice daily
- With CYP3A inducers (e.g., efavirenz without strong inhibitor): 600 mg twice daily
CELSENTRI should be taken with or without food, and always in combination with other HIV medications.
Hepatotoxicity: Cases of liver toxicity with allergic features reported. Discontinue if signs of liver damage or systemic reactions appear.
Liver Conditions: Use with caution in patients with hepatic impairment or hepatitis B/C co-infection.
Cardiovascular Risk: Exercise caution in patients with a history of heart disease or those taking medications that lower blood pressure.
Immune Reconstitution Syndrome: May occur with antiretroviral therapy including Maraviroc.
Infection Risk: As a CCR5 antagonist, it may increase susceptibility to infections. Patients should be monitored closely.
Documents required for import to India:
- Valid prescription from a registered doctor
- Diagnostic reports related to HIV infection
- Government-issued photo ID proof of the patient
- Import permit, if required
Availability in India:
CELSENTRI is not approved for retail sale in India but may be accessed through Named Patient Import, following proper documentation and permissions. Global Rare Meds can arrange delivery to all major cities including Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Ahmedabad, Pune, Jaipur, Chandigarh, and others.
Global Rare Meds sources CELSENTRI (Maraviroc) from authorized and globally accredited suppliers based in the USA, Europe, Canada, and Australia.
- Orders dispatched from our Ambernath-based fulfillment center in Thane District
- Dispensation only after pharmacist verification of prescriptions
- Secure, compliant, and documented delivery process across India and select international location
We ensure complete transparency, genuine medicines, and reliable delivery timelines.
What is the generic name of CELSENTRI?
Maraviroc
Who manufactures CELSENTRI?
Pfizer
What is CELSENTRI used for?
It is used in combination therapy for HIV-1 infection in patients with CCR5-tropic HIV-1.
Is CELSENTRI approved by the FDA?
Yes, it is approved by the U.S. FDA for medical use.
What are the available strengths of CELSENTRI?
Tablets of 150 mg and 300 mg are available.
Can I buy CELSENTRI in India?
Yes, under Named Patient Supply with valid documentation and necessary permissions.
Is CELSENTRI available in generic form?
Currently, there are no generic or biosimilar versions of Maraviroc available.
How can I get the price of CELSENTRI in India?
Contact Global Rare Meds at:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
